Long-term medication persistence in stroke patients treated with intravenous thrombolysis

Highlights • Long-term medication persistence is higher among thrombolysed stroke patients. • The highest long-term persistence is to antiplatelet and antihypertensive drugs. • Patients with less stroke disability have higher long-term medication persistence. • Medication persistence is higher among...

Full description

Saved in:
Bibliographic Details
Published in:Clinical neurology and neurosurgery 2016-02, Vol.141, p.19-22
Main Authors: Budimkic, Maja Stefanovic, Pekmezovic, Tatjana, Beslac-Bumbasirevic, Ljiljana, Ercegovac, Marko, Berisavac, Ivana, Stanarcevic, Predrag, Padjen, Visnja, Jovanovic, Dejana R
Format: Article
Language:English
Subjects:
Administration, Intravenous
Blood platelets
Cardiac arrhythmia
Female
Fibrinolytic Agents - administration & dosage
Follow-Up Studies
Funding
Hospitals
Humans
Hypertension
Intravenous thrombolysis
Male
Medication Adherence
Medication persistence
Middle Aged
Neurology
Neurosurgery
Patients
Prevention
Retrospective Studies
Stroke
Stroke - diagnosis
Stroke - drug therapy
Stroke outcome
Thrombolytic Therapy - trends
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Long-term medication persistence is higher among thrombolysed stroke patients. • The highest long-term persistence is to antiplatelet and antihypertensive drugs. • Patients with less stroke disability have higher long-term medication persistence. • Medication persistence is higher among IVT-treated patients compared to non-IVT-treated patients. • The higher rate of non-medication persistence was recorded in patients with more pronounced disabilities after stroke.
ISSN:0303-8467
1872-6968
DOI:10.1016/j.clineuro.2015.12.003